Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
What is the Main Function of GLP-1
Retatrutide remains investigational and should not be self-sourced
These medications may have a half-life of 1.5 hours to five days
Both hormones play key roles in appetite regulation
For women navigating perimenopause or menopause, microdosing GLP-1 for menopause symptoms represents a potential tool for addressing metabolic changes during this transition
Dosing fundamentals Administration: Once weekly subcutaneous injection Same day each week (consistency matters) Preferably at the same time of day Half-life: Approximately 6 days, supporting weekly dosing Dose escalation: Every 4 weeks, unless: Side effects require holding current dose Individual tolerance suggests faster/slower progression Healthcare provider recommends adjustment Clinical trial doses tested The Phase 2 obesity trial tested multiple dosing arms: Key insight: 8 mg produces nearly the same results as 12 mg with fewer side effectsmaking it a potential "sweet spot" for many users
